Experience that starts with understanding your knee
After more than 1,200 Arthrosamid injections, Professor Lee’s clinical experience extends beyond the procedure itself. His approach brings together assessment, injection technique and follow-up, with a practical aim: helping patients make a treatment decision that fits their knee and the activities that matter to them.
Arthrosamid can offer symptom relief for knee osteoarthritis. Responses vary, so the consultation is an opportunity to understand where it may help you and what a worthwhile improvement could look like. That conversation is part of the care, not a hurdle to treatment.
What is causing your symptoms?
Professor Lee’s published account of his practice emphasises patient selection and clinical decision-making. For someone considering Arthrosamid, the starting point is a clear picture of the problem: your symptoms, previous treatment, examination and relevant imaging.
It helps to describe what happens in daily life. Is walking uncomfortable? Do stairs interrupt your routine? Have you stopped an activity you enjoy? Bring details of earlier injections, including whether they helped and for how long. Those experiences give the consultation more useful context than the name of a treatment alone.
Where assessment identifies a problem that Arthrosamid is unlikely to address, the discussion should turn to the options that better fit it. The purpose is to find a useful way forward.
Make the goal personal and practical
A useful goal is something you can recognise in your own life: a more comfortable walk, easier everyday movement or less disruption from knee symptoms. Discuss your priorities with the clinician so that the expected benefit, recovery plan and review can be considered together.
Arthrosamid is a treatment for symptoms, rather than a promise to restore a joint to its original condition. Being clear about that distinction makes it easier to judge meaningful progress without overlooking improvements that matter to you.
Follow-up is part of the treatment decision
Professor Lee co-authored a prospective study following 269 patients with 314 treated knees for 24 months. Average pain and function scores improved. The researchers also explored how patient characteristics related to outcomes, underlining why individual assessment matters.
Before treatment, ask how and when your progress will be reviewed, what changes to report and whom to contact with questions. A clear plan gives you a point of contact and a way to discuss how recovery is going.
When improvement falls short of your goals
Arthrosamid does not work equally well for everyone. If the improvement is less than you hoped for, the next step is a review of your symptoms and response. That review can consider whether the original treatment aim is being met and whether another part of your care needs attention.
A further injection should be a considered decision, rather than an automatic response to persistent symptoms. Depending on the assessment, the conversation may cover continued follow-up, another treatment approach or a surgical opinion. There is still a care decision to make; you should understand the options and the reasoning behind them.
Start with a conversation about your options
You do not need to decide on an injection before contacting AMSK. A free discovery call with the admin team can explain the assessment process and practical arrangements. The clinical consultation is where suitability, expected benefits, risks and alternatives are discussed for your individual knee.
The aim is to leave that consultation with a clearer understanding of your options and a plan you feel informed about.
Sources and further reading
- Professor Lee: joint injections and clinical experience
- Gao et al. (2025): 24-month prospective knee cohort
- Published correction: ethics approval reference
General information to support a clinical conversation. AMSK and Professor Lee are part of the MSK Doctors group; group publications are identified above.
Editorial review notes · Preview only
The cohort now supports the follow-up and selection discussion. Optional addition for Paul: a de-identified case illustrating how assessment changed the plan. No invented patient story or automatic selection rule.


